1. Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020 Subject(s): Blood DonorsBlood TransfusionCreutzfeldt-Jakob Syndrome -- prevention & controlCreutzfeldt-Jakob Syndrome -- transmissionUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020 Subject(s): Blood DonorsBlood TransfusionHIVHIV Infections -- prevention & controlUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Revised recommendations to reduce the risk of transfusion-transmitted malaria Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020 Subject(s): Blood DonorsBlood TransfusionMalaria -- prevention & controlMalaria -- transmissionUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
4. Alternative procedures for blood and blood components during the COVID-19 public health emergency Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020 Subject(s): Blood DonorsBlood TransfusionPlasmaCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
